PBA Use for Treatment of ATF6-/- Patients | MicrobiomeTrials← Back to trialsNCT04041232
PBA Use for Treatment of ATF6-/- Patients
SUSPENDEDEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2025-04-08Est. Completion: 2027-08
Enrollment target: 2 participants Locations- Columbia University Irving Medical Center, New York, New York, United States
Other microbiome trials you might be interested in
Inherited Retinal Diseases
The purpose of this study is to better understand the natural history of Inherited Retinal Disease (IRD) and help inform…
Birmingham, United StatesCompleted Jul 2, 2026
Achromatopsia
This will be a non-randomized, open-label, Phase 1/2 study of the safety and efficacy of AGTC-402, administered to one e…
Gainesville, United StatesCompleted Aug 2022